Search research articles
Contact Us
Filters
Showing results (111-120 of 471) with videos related to
Page
of 48
Sort By:
European Journal of Heart Failure
|
June 28, 2013
Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study
Luigi Tavazzi, Karl Swedberg, Michel Komajda, et al.
European Journal of Heart Failure
|
September 18, 2015
Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial
Michel Komajda, Luigi Tavazzi, Bernard G Francq, et al.
BMJ Open
|
July 22, 2020
Person-centred care by a combined digital platform and structured telephone support for people with chronic obstructive pulmonary disease and/or chronic heart failure: study protocol for the PROTECT randomised controlled trial
Lilas Ali, Sara Wallström, Emmelie Barenfeld, et al.
Journal of the American College of Cardiology
|
July 11, 2009
Dual renin-angiotensin system blockade in heart failure
John J V McMurray, Christopher B Granger, Jan Ostergren, et al.
Cardiology
|
May 14, 2015
Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population
Edimar Alcides Bocchi, Michael Böhm, Jeffrey S Borer, et al.
Journal of Cardiac Failure
|
May 10, 2005
Symptoms in patients with heart failure are prognostic predictors: insights from COMET
Inger Ekman, John G F Cleland, Karl Swedberg, et al.
European Heart Journal
|
December 23, 2006
Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I
Michel Komajda, Olivier Hanon, Matthias Hochadel, et al.
Thrombosis Research
|
September 19, 2009
Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure--a COMET substudy
Kurt Boman, Jan-Håkan Jansson, Torbjörn Nilsson, et al.
European Journal of Heart Failure
|
August 16, 2012
Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine's effects in patients with chronic heart failure
Michel Komajda, Michael Böhm, Jeffrey Borer, et al.
The American Journal of Cardiology
|
October 26, 2002
Relation of circulating cardiac myosin light chain 1 isoform in stable severe congestive heart failure to survival and treatment with flosequinan
Mark S Hansen, Eric B Stanton, Yehia Gawad, et al.
Page
of 48
Search research articles
Search
Showing results (111-120 of 471) with videos related to
Sort By:
Page
of 48
European Journal of Heart Failure
|
June 28, 2013
Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study
Luigi Tavazzi, Karl Swedberg, Michel Komajda, et al.
European Journal of Heart Failure
|
September 18, 2015
Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial
Michel Komajda, Luigi Tavazzi, Bernard G Francq, et al.
BMJ Open
|
July 22, 2020
Person-centred care by a combined digital platform and structured telephone support for people with chronic obstructive pulmonary disease and/or chronic heart failure: study protocol for the PROTECT randomised controlled trial
Lilas Ali, Sara Wallström, Emmelie Barenfeld, et al.
Journal of the American College of Cardiology
|
July 11, 2009
Dual renin-angiotensin system blockade in heart failure
John J V McMurray, Christopher B Granger, Jan Ostergren, et al.
Cardiology
|
May 14, 2015
Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population
Edimar Alcides Bocchi, Michael Böhm, Jeffrey S Borer, et al.
Journal of Cardiac Failure
|
May 10, 2005
Symptoms in patients with heart failure are prognostic predictors: insights from COMET
Inger Ekman, John G F Cleland, Karl Swedberg, et al.
European Heart Journal
|
December 23, 2006
Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I
Michel Komajda, Olivier Hanon, Matthias Hochadel, et al.
Thrombosis Research
|
September 19, 2009
Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure--a COMET substudy
Kurt Boman, Jan-Håkan Jansson, Torbjörn Nilsson, et al.
European Journal of Heart Failure
|
August 16, 2012
Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine's effects in patients with chronic heart failure
Michel Komajda, Michael Böhm, Jeffrey Borer, et al.
The American Journal of Cardiology
|
October 26, 2002
Relation of circulating cardiac myosin light chain 1 isoform in stable severe congestive heart failure to survival and treatment with flosequinan
Mark S Hansen, Eric B Stanton, Yehia Gawad, et al.
Page
of 48